PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia

Leuk Res. 2010 Dec;34(12):e323-5. doi: 10.1016/j.leukres.2010.07.035. Epub 2010 Aug 17.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / genetics*
  • Blood Cell Count
  • Child, Preschool
  • Chromosomes, Human, Pair 7 / genetics*
  • Chromosomes, Human, Pair 9 / genetics*
  • Cytoskeletal Proteins
  • Female
  • Humans
  • Oncogene Proteins, Fusion / genetics*
  • PAX5 Transcription Factor / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / blood
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / classification*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Proteins / genetics*
  • Transcription Factors
  • Translocation, Genetic / genetics*

Substances

  • AUTS2 protein, human
  • Biomarkers, Tumor
  • Cytoskeletal Proteins
  • Oncogene Proteins, Fusion
  • PAX5 Transcription Factor
  • PAX5 protein, human
  • PAX5-AUTS2 fusion protein, human
  • Proteins
  • Transcription Factors